We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-1.87%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$95.8B
AUM Growth
-$2.11B
Cap. Flow
-$2.99B
Cap. Flow %
-3.13%
Top 10 Hldgs %
11.73%
Holding
4,689
New
482
Increased
1,493
Reduced
1,535
Closed
473

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$584M
2
TSLA icon
Tesla
TSLA
+$483M
3
NVDA icon
NVIDIA
NVDA
+$444M
4
LLY icon
Eli Lilly
LLY
+$345M
5
TMUS icon
T-Mobile US
TMUS
+$296M

Sector Composition

Rank Sector Weight
1 Technology 16.67%
2 Consumer Discretionary 9.3%
3 Healthcare 7.82%
4 Financials 5.66%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
3651
Recursion Pharmaceuticals
RXRX
$1.57B
$181K ﹤0.01%
23,707
+11,862
+100% +$118K
PMVP icon
3652
PMV Pharmaceuticals
PMVP
$66.1M
$177K ﹤0.01%
28,798
-32,473
-53% -$223K
SVM
3653
Silvercorp Metals
SVM
$2.13B
$177K ﹤0.01%
75,900
+64,000
+538% +$174K
ETWO
3654
DELISTED
E2open Parent Holdings
ETWO
$176K ﹤0.01%
38,680
+22,380
+137% +$111K
EVRI
3655
DELISTED
Everi Holdings
EVRI
$175K ﹤0.01%
13,243
-28,352
-68% -$403K
STEM icon
3656
PUT
Stem
STEM
$49.2M
$174K ﹤0.01%
2,050
OGN icon
3657
CALL
Organon & Co
OGN
$3.55B
$174K ﹤0.01%
+10,000
New +$209K
IOVA icon
3658
Iovance Biotherapeutics
IOVA
$2.23B
$172K ﹤0.01%
37,762
-820,994
-96% -$5.36M
PETS icon
3659
PetMed Express
PETS
$42.5M
$172K ﹤0.01%
16,750
-9,435
-36% -$116K
BALY icon
3660
PUT
Bally's
BALY
$672M
$168K ﹤0.01%
12,800
CFB
3661
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$168K ﹤0.01%
16,607
-3,343
-17% -$36.4K
AFCG
3662
AFC Gamma
AFCG
$58.6M
$167K ﹤0.01%
20,774
-28,139
-58% -$250K
CLSK icon
3663
CleanSpark
CLSK
$3.73B
$166K ﹤0.01%
43,532
-605,135
-93% -$3.2M
HA
3664
DELISTED
Hawaiian Holdings, Inc.
HA
$164K ﹤0.01%
+25,972
New +$246K
DIBS icon
3665
1stdibs.com
DIBS
$145M
$164K ﹤0.01%
45,068
+436
+1% +$1.74K
STHO icon
3666
Star Holdings Shares of Beneficial Interest
STHO
$112M
$162K ﹤0.01%
12,901
+2,200
+21% +$30.6K
AGRO icon
3667
Adecoagro
AGRO
$1.53B
$158K ﹤0.01%
13,534
-15,962
-54% -$172K
GBDC icon
3668
Golub Capital BDC
GBDC
$3.33B
$156K ﹤0.01%
+10,600
New +$150K
LAND
3669
Gladstone Land Corp
LAND
$368M
$152K ﹤0.01%
+10,685
New +$170K
PRLD icon
3670
Prelude Therapeutics
PRLD
$305M
$152K ﹤0.01%
49,184
-6,654
-12% -$25K
CGC
3671
Canopy Growth
CGC
$375M
$152K ﹤0.01%
19,403
-347,965
-95% -$2.13M
BLFY
3672
DELISTED
Blue Foundry Bancorp
BLFY
$151K ﹤0.01%
18,014
+1,157
+7% +$11K
ETWO.WS
3673
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$150K ﹤0.01%
319,896
+150,000
+88% +$75.7K
STKL
3674
DELISTED
SunOpta
STKL
$149K ﹤0.01%
44,500
+650
+1% +$3.26K
BMBL icon
3675
CALL
Bumble
BMBL
$367M
$149K ﹤0.01%
10,000

Similar funds

D.E. Shaw & Co's Q3 2023 Portfolio in Review

As of Q3 2023, D.E. Shaw & Co held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co withdrew a net $2.99B in Q3 2023, closing 473 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.

  • D.E. Shaw & Co's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
  • D.E. Shaw & Co added most to Amazon in Q3 2023, an estimated $516M increase.
  • D.E. Shaw & Co's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
  • D.E. Shaw & Co fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
  • D.E. Shaw & Co opened 482 new positions and closed 473 in Q3 2023.
  • D.E. Shaw & Co's portfolio value fell 2.2% quarter-over-quarter to $95.8B.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.